Prokidney (PROK) Payables (2021 - 2026)

Prokidney (PROK) has reported Payables for 6 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 34.1% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $1.6 million, a 34.1% decrease from a year earlier, with the FY2025 full-year figure at $940000.0, down 74.13% from the prior year.
• Payables was $1.6 million for Q2 2026 at Prokidney, down from $2.6 million in the prior quarter.
• Over five years, Payables peaked at $5.1 million in Q4 2023 and troughed at $70358.0 in Q1 2022.
• A 5-year average of $2.7 million and a median of $2.9 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables surged 6162.47% in 2022 and tumbled 74.13% in 2025, its largest moves.
• Over 5 years, Payables stood at $3.0 million in 2022, then jumped by 67.48% to $5.1 million in 2023, then slipped by 28.74% to $3.6 million in 2024, then plunged by 74.13% to $940000.0 in 2025, then soared by 71.28% to $1.6 million in 2026.
• The last three Payables figures came in at $1.6 million (Q2 2026), $2.6 million (Q1 2026), and $940000.0 (Q4 2025), per Business Quant data.